Glenmark gets final nod from USFDA for angina treatment drug

The product is a generic version of Gilead Sciences Inc's Ranexa extended-release tablets in the same strengths.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Jo47Uv
via IFTTT